| Earnings Per Share Our earnings per common share (“EPS”) were: | | | | | | | | | | | | | | | | | For the Three Months Ended | | | | March 28, 2026 | | March 29, 2025 | | | | | | | (in millions, except per share data) | | Basic Earnings Per Common Share: | | | | | | | | | Net income/(loss) attributable to common shareholders | $ | 798 | | | $ | 712 | | | | | | | Weighted average shares of common stock outstanding | 1,185 | | | 1,194 | | | | | | | Net earnings/(loss) | $ | 0.67 | | | $ | 0.60 | | | | | | | Diluted Earnings Per Common Share: | | | | | | | | | Net income/(loss) attributable to common shareholders | $ | 798 | | | $ | 712 | | | | | | | Weighted average shares of common stock outstanding | 1,185 | | | 1,194 | | | | | | | Effect of dilutive equity awards | 3 | | | 4 | | | | | | | Weighted average shares of common stock outstanding, including dilutive effect | 1,188 | | | 1,198 | | | | | | | Net earnings/(loss) | $ | 0.67 | | | $ | 0.59 | | | | | |
We use the treasury stock method to calculate the dilutive effect of outstanding equity awards in the denominator for diluted EPS. Anti-dilutive shares were 7 million for the three months ended March 28, 2026 and 6 million for the three months ended March 29, 2025.
|